Zuwen Zhou

This inventor holds 12 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Shanghai Fochon Pharmaceutical Co., Ltd., Fochon Pharmaceuticals, Ltd., Chongqing Fochon Pharmaceutical Co., Ltd.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zuwen Zhou. Retrieved from https://idiyas.com/inventor/zuwen-zhou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 5)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 15.2

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

8 out of 13

Shanghai Fochon Pharmaceutical Co., Ltd.

patents

4 out of 7

Fochon Pharmaceuticals, Ltd.

patents

2 out of 3

Chongqing Fochon Pharmaceutical Co., Ltd.

patents

4. 1 out of 3,376

Chinese Academy of Sciences

patents

5. 1 out of 2

Fochon Biosciences, Ltd.

patents

6. 1 out of 1

Fochon Pharmaceutical Co., Ltd.

patent

7. 1 out of 4

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

patents

where one patent can have more than one assignee

Years Active: 2017-2025

Loading Chart...

Areas of Expertise:

Apoptosis-Inducing Agents

Protein Kinase Inhibitors

Quinazoline Derivatives

Indolizine Derivatives

TRK Kinase Inhibitors

BLC-2-Selective Agents

Compositions

Pharmaceuticals

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312349 - Apoptosis-inducing agents (2025-05-27),

2. 11459332 - Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors (2022-10-04),

3. 11091478 - Apoptosis-inducing agents (2021-08-17),

4. 11053239 - Compounds as BLC-2-selective apoptosis-inducing agents (2021-07-06),

5. 10894038 - Indolizine derivatives, composition and methods of use (2021-01-19),

6. 10835535 - Certain protein kinase inhibitors (2020-11-17),

7. 10450316 - Certain protein kinase inhibitor (2019-10-22),

8. 10328060 - Certain protein kinase inhibitors (2019-06-25),

9. 10053449 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals (2018-08-21),

10. 10022374 - Certain protein kinase inhibitors (2018-07-17),

11. 9714235 - Quinazoline derivatives, compositions thereof, and use as pharmaceuticals (2017-07-25),

12. 9556171 - Certain protein kinase inhibitors (2017-01-31),

Title: Inventor Zuwen Zhou: Revolutionizing Technology in Chongqing

Introduction: Zuwen Zhou is a pioneering inventor based in Chongqing, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Zuwen Zhou holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Zuwen Zhou has worked tirelessly to develop cutting-edge solutions that have the potential to shape the future of technology. His dedication to innovation and problem-solving has earned him recognition as a leading figure in the industry.

Collaborations: Throughout his career, Zuwen Zhou has collaborated with top research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Zuwen Zhou's passion for innovation and his relentless pursuit of excellence continue to drive him towards new discoveries and advancements in the field of technology. His work serves as an inspiration to aspiring inventors and underscores the importance of creativity and perseverance in the world of innovation.

Profile summary based on public USPTO records.